Efficacy of venetoclax plus anti‐CD38 monoclonal antibody‐containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody. (20th November 2022) - Regidor, Bernard Sean; Siddiqi, Dilawer; Beatty, Bethany Marie; Goldwater, Marissa‐Skye; Jew, Scott; Bujarski, Sean; Swift, Regina; Kim, Susanna; Berenson, James R.